NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
P/E ratio for NEUCA S.A. (NEU.WA)
P/E ratio as of 2023: 27.78
According to NEUCA S.A.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.78. At the end of 2022 the company had a P/E ratio of 20.65.
P/E ratio history for NEUCA S.A. from 2005 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 27.78 |
| 2022 | 20.65 |
| 2021 | 24.47 |
| 2020 | 19.84 |
| 2019 | 13.87 |
| 2018 | 12.64 |
| 2017 | 12.93 |
| 2016 | 15.39 |
| 2015 | 15.77 |
| 2014 | 10.72 |
| 2013 | 14.96 |
| 2012 | 6.45 |
| 2011 | 5.76 |
| 2010 | 9.06 |
| 2009 | 8.56 |
| 2008 | 11.67 |
| 2007 | 15.76 |
| 2006 | 17.13 |
| 2005 | 10.75 |